Association between albuminuria, carotid atherosclerosis, arterial stiffness, and peripheral arterial disease in korean type 2 diabetic patients

Kidney and Blood Pressure Research

Volumn 33, Issue 2, 2010, Pages 111-118

  Choi, Seong Woo ^a   Yun, Woo Jun ^a   Kim, Hey Yeon ^b   Lee, Young Hoon ^c   Kweon, Sun Seog ^a,d   Rhee, Jung Ae ^a   Choi, Jin Su ^a   Shin, Min Ho ^a  

^a Chonnam National University Medical School   (South Korea)

^b Seonam University   (South Korea)

^c Chonnam National University Medical School   (South Korea)

^d Chonnam National University   (South Korea)

Author keywords

Albuminuria; Arterial stiffness; Carotid atherosclerosis; Korean type 2 diabetic patients; Peripheral arterial disease

Indexed keywords

ALBUMIN; CREATININE; INSULIN; ORAL ANTIDIABETIC AGENT;

AGED; ALBUMINURIA; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTERY DISEASE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PULSE WAVE; ARTERY; CAROTID ARTERY DISEASES; COMPLICATION; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASES; VASCULAR RESISTANCE;

AGED; ALBUMINURIA; ARTERIES; CAROTID ARTERY DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; KOREA; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; VASCULAR RESISTANCE;

EID: 77951589814     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313594     Document Type: Article

References (48)

1. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes -estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
2. Pan WH, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, et al: Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 1986; 123: 504-516.
3. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444.
4. Gerstein HC, Mann JFE, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-426.
5. Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, et al: Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 2003; 139: 901-906.
6. Dinneen SF, Gerstein HC: The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med 1997; 157: 1413-1418.
7. Mathiesen ER, Ronn B, Storm B, Foght H, Deckert T: The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study. Diabet Med 1995; 12: 482-487.
8. Touboul PJ, Elbaz A, Koller C, Lucas C, Adrai V, Chedru F, et al: Common carotid artery intima-media thickness and brain infarction. GENIC case-control study. Circulation 2000; 102: 313-318.
9. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK J: Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 340: 14-22.
10. Grobbee DE, Bots ML: Carotid intima-media thickness as an indicator of generalized atherosclerosis. J Intern Med 1994; 236: 567-573.
11. Androulakis AE, Andrikopoulos GK, Richter DJ, Tentolouris CA, Avgeropoulou CC, Adamopoulos DA, et al: The role of carotid atherosclerosis in the distinction between ischemic and non-ischemic cardiomyopathy. Eur Heart J 2000; 21: 919-926.
12. Golledge J, Greenhalgh RM, Davies AH: The symptomatic carotid plaque. Stroke 2000;31: 774-781.
13. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, et al: Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 2004; 109: 733-739.
14. Blacher J, Asmar R, Djane S, London GM, Safar ME: Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33: 1111-1117.
15. Yokoyama H, Hirasawa K, Aoki T, Ishiyama M, Koyama K: Brachial-ankle pulse wave velocity measured automatically by oscillometric method is elevated in diabetic patients with incipient nephropathy. Diabet Med 2003; 20: 942-945.
16. Tkac I, Molcanyiova A: Fibrinogen and albuminuria are related to the presence and severity of peripheral arterial disease in women with type 2 diabetes mellitus. Angiology 1997; 48: 715-719.
17. Stefan A, Fagerberg B: Microalbuminuria and intima-media thickness of the carotid artery in clinically healthy men. Atherosclerosis 2002; 164: 161-166.
18. Kramer H, Jacobs DR Jr, Bild D, Post W, Saad MF, Detrano R, et al: Urine albumin excretion and subclinical cardiovascular disease. Hypertension 2005; 46: 38-43.
19. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
20. Lustgarten JA, Wink RE: Simple rapid kinetic method for serum creatinine measurement. Clin Chem 1972; 18: 1419.
21. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, et al: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470.
22. Ishizakaa Y, Ishizaka N, Tani M, Toda A, Toda EI, Koike K, et al: Relationship between albuminuria, low eGFR, and carotid atherosclerosis in Japanese women. Kidney Blood Pressure Res 2008; 31: 164-170.
23. Freedman BI, Langefeld CD, Lohman KK, Bowden DW, Carr JJ, Rich SS, et al: Relationship between albuminuria and cardiovascular disease in type 2 diabetes. J Am Soc Nephrol 2005; 16: 2156-2161.
24. Mathiesen ER, Rønn B, Storm B, Foght H, Deckert T: The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study. Diabet Med 1995; 12: 482-487.
25. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219-226.
26. Finn AV, Kolodgie FD, Virmani R: Correlation between carotid intimal/medial thickness and atherosclerosis. A point of view from pathology. Arterioscler Thromb Vasc Biol 2010; 30: 177-181.
27. Megnien JL, Simon A, Gariepy J, Denarie N, Cocaul M, Linhart A, et al: Preclinical changes of extracoronary arterial structures as indicators of coronary atherosclerosis in men. J Hypertens 1998; 16: 157-163.
28. Ishimura E, Taniwaki H, Tsuchida T, Obatake N, Emoto M, Shoji T, et al: Urinary albumin excretion associated with arterial wall stiffness rather than thickness in type 2 diabetic patients. J Nephrol 2007; 20: 204-211.
29. Safar ME, London GM: Structure fTCCoA, function: therapeutic studies and arterial stiffness in hypertension: recommendations of the European Society of Hypertension. J Hypertens 2000; 18: 1527-1535.
30. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al: Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
31. Munakata M, Ito N, Nunokawa T, Yoshinaga K: Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens 2003; 16: 653-657.
32. Sugawara J, Hayashi K, Yokoi T, Cortez-Cooper MY, DeVan AE, Anton MA, et al: Brachial-ankle pulse wave velocity: an index of central arterial stiffness? J Hum Hypertens 2005;19: 401-406.
33. Munakata M, Nunokawa T, Tayama J, et al: Brachial-ankle pulse wave velocity as a novel measure of arterial stiffness: present evidence. Curr Hypertens Rev 2005; 1: 223-234.
34. Dart AM, Kingwell BA: Pulse pressure -a review of mechanisms and clinical relevance. J Am Coll Cardiol 2001; 37: 975-984.
35. O'Rourke MF, Safar ME: Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005; 46: 200-204.
36. Knight EL, Kramer HM, Curhan GC: Highnormal blood pressure and microalbuminuria. Am J Kidney Dis 2003; 41: 588-595.
37. Kohara K, Tabara Y, Tachibana R, Nakura J, Miki T: Microalbuminuria and arterial stiffness in a general population: the Shimanami Health Promoting Program (J-SHIPP) Study. Hypertens Res 2004; 27: 471-477.
38. Jie JC, Joshua IB, Do P, Teri AM, Bruce MP, Lewis K, et al: The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: the Cardiovascular Health Study. Atherosclerosis 2006; 187: 372-377.
39. Tseng CH, Chong CK, Tseng CP, Tai TY: The association between urinary albumin excretion and ankle-brachial index in elderly Taiwanese patients with type 2 diabetes mellitus. Age Ageing 2008; 37: 77-82.
40. Forrest KY, Becker DJ, Kuller LH, Wolfson SK, Orchard TJ: Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study. Atherosclerosis 2000; 148: 159-169.
41. Blumenthal HT, Berns AW, Goldenberg S, Lowenstein PW: Etiologic considerations in peripheral vascular diseases of the lower extremity with special reference to diabetes mellitus. Circulation 1966; 33: 98-106.
42. Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJM, Holman RR: UKPDS 59: Hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 2002; 25: 894-899.
43. Stehouwer CDA: Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for non-diabetic renal disease. Nephrol Dial Transplant 2004; 19: 778-781.
44. Stehouwer CDA, Smulders YM: Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol 2006; 17: 2106-2111.
45. Deen WM: What determines glomerular capillary permeability? J Clin Investig 2004; 114: 1412-1414.
46. Samuelsson O, Mulec H, Knight-Gibson C, Attman P, Kron B, Larrson R, et al: Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant 1997; 12: 1908-1915. (Pubitemid 27379464)
47. Kamanna VS, Roh DD, Kirschenbaum MA: Hyperlipidemia and kidney disease: concepts derived from histopathology and cell biology of the glomerulus. Histol Histopathol 1998; 13: 169-179.
48. Hutchison A, O'Reilly D, MacCuish A: Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria. Clin Chem 1988; 34: 2019-2021.